First of all, sorry if I write something bad in english ....
Last week I visited an eye doctor in Madrid. I asked her about the possibility of do a FOV in the near future an she basicaly said "no" because it has a lot of risk ..... I told her that in the case I needed it and I could not bear floaters longer, I should go abroad for a FOV. I think she realized that I was speaking seriously and then she told me that if I can convince the doctor that I really need it, it can be done in Spain, and that in Spain there are very good eye doctors and I wouldn't have to go abroad in the case I really need it.
About ocriplasmin, I think she was not very interested. She told me this would cause me more floaters, and I said, yes, but this would make easy a vitrectomy... she only said, may be.
Then she said that there is an investigation with a molecule that disolves vitreous opacities, It was starting now so it could last 10 years to be in the market, but she suggested me that I can be involve in the tests... I made a mistake and told her that prefer a vitrectomy (risks, but something probed) than a injection of something that is not tested and the conversation ended.
After that I've been looking for what could be the molecule she was talking about and I've found this:
"Allegro’s compound produces rapid, complete liquefaction of the rabbit vitreous and induces PVD within one to two days with no apparent toxicity or immunologic side effects."
If this molecule really can licufy vitreous, then I think it could be a solution for floaters, but the investigation is for DME, not for floaters. I think this investigation is now in phase II (I'm not sure), and my doubt is if it reach phase III a person with floaters (not DME) could be a candidate to try this or has to wait to the complete cycle?.
Do you think this could be a solution for us?.